Published in Acta Diabetol Lat on January 03, 1986
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care (2015) 1.12
Intranasal glucagon: a promising approach for treatment of severe hypoglycemia. J Diabetes Sci Technol (2014) 0.75
Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med (1990) 3.21
Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med (1988) 2.44
Early closure of European Pimagedine trial. Steering Committee. Safety Committee. Lancet (1997) 2.28
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia (1996) 2.15
High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes (2001) 2.02
Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. Br Med J (Clin Res Ed) (1982) 1.90
Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int (2001) 1.58
Isolation of the elusive pig islet. Surgery (1990) 1.56
Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin. Hum Gene Ther (1999) 1.48
Effects of cryopreservation on in vitro and in vivo long-term function of human islets. Transplantation (1999) 1.47
Minimal models of glucose disappearance: lessons from the labelled IVGTT. Diabet Med (1991) 1.45
Pancreas transplantation. Lancet (1994) 1.36
Pancreatoduodenectomy with occlusion of the residual stump by Neoprene injection. World J Surg (1989) 1.28
Autoantibody response to islet transplantation in type 1 diabetes. Diabetes (2001) 1.26
Hypocaloric high-protein diet improves glucose oxidation and spares lean body mass: comparison to hypocaloric high-carbohydrate diet. Metabolism (1994) 1.22
Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation. Diabetologia (1983) 1.22
Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics. Kidney Int (1987) 1.15
Glucose metabolism alterations in Friedreich's ataxia. Neurology (1988) 1.15
Plasmapheresis in the treatment of stiff-man syndrome. N Engl J Med (1989) 1.11
Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care (2001) 1.10
Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia (1990) 1.10
Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes (2000) 1.07
Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med (2010) 1.07
Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients. Diabetes Care (1989) 1.05
Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes (1978) 1.03
Intranasal glucagon raises blood glucose concentrations in healthy volunteers. Br Med J (Clin Res Ed) (1983) 1.02
Mechanisms of coordination of Ca2+ signals in pancreatic islet cells. Diabetes (1999) 1.02
Imaging of the buffering effect of insulin antibodies in the autoimmune hypoglycemic syndrome. J Clin Endocrinol Metab (1998) 0.99
Glibenclamide: an old drug with a novel mechanism of action? Acta Diabetol (1997) 0.98
Endocrinometabolic effects of whole versus segmental pancreas allotransplantation in diabetic patients--a two-year follow-up. Transplantation (1991) 0.97
Metabolic control of type I (insulin dependent) diabetes after pancreas transplantation. Br Med J (Clin Res Ed) (1985) 0.97
Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab (2014) 0.96
Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity. Nutr Metab Cardiovasc Dis (2008) 0.96
Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects. J Clin Endocrinol Metab (1993) 0.95
Patients with insulinoma show insulin resistance in the absence of arterial hypertension. Diabetologia (1992) 0.94
Field experiences in the control of avian influenza outbreaks in densely populated poultry areas. Dev Biol (Basel) (2004) 0.94
Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J Clin Endocrinol Metab (1991) 0.93
Association of obesity and type II diabetes mellitus as a risk factor for gallstones. Dig Dis Sci (2000) 0.93
Effectiveness and safety of laparoscopic adrenalectomy. J Urol (1994) 0.93
Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management. Diabetes Metab Rev (1994) 0.92
Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients. Diabetes Care (2000) 0.91
Stage of change and motivation to healthy diet and habitual physical activity in type 2 diabetes. Acta Diabetol (2014) 0.91
Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis (2008) 0.91
Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas. Diabetologia (1997) 0.90
Dihydropyridine-sensitive and -insensitive voltage-operated calcium channels participate in the control of glucose-induced insulin release from human pancreatic beta cells. J Endocrinol (1996) 0.90
Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial. Diabetes Obes Metab (2011) 0.90
Peripheral T-lymphocytes in juvenile-onset diabetics (JOD) and in maternity-onset diabetics (MOD). Diabetes (1976) 0.90
Effect of pancreas transplantation on life expectancy, kidney function and quality of life in uraemic type 1 (insulin-dependent) diabetic patients. Diabetologia (1991) 0.89
Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes (1996) 0.89
The effect of histamine and H1 and H2 receptors on prolactin and luteinizing hormone release in humans: sex differences and the role of stress. J Clin Endocrinol Metab (1981) 0.89
Insights from a successful case of intrahepatic islet transplantation into a type 1 diabetic patient. J Clin Endocrinol Metab (2000) 0.89
Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies. J Autoimmun (1991) 0.88
Bilateral eighth cranial nerve neuropathy in human immunodeficiency virus infection. J Neurol (1993) 0.88
Prevalence of retinopathy in diabetic subjects from out-patient clinics in Lombardy (Italy), and associated risk factors. A multicentre epidemiologic study. Diabetes Res Clin Pract (1989) 0.88
Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients. AIDS Res Hum Retroviruses (2005) 0.88
Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes (2001) 0.88
Plasma protein glycation as measured by fructosamine assay. Clin Chem (1987) 0.88
Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Diabetologia (2011) 0.88
Islet transplantation in IDDM patients. Diabetologia (1997) 0.88
Long-term metabolic effects of segmental pancreas transplantation. Transplant Proc (1990) 0.87
Techniques of pancreas transplantation through the world: an IPITA Center survey. Transplant Proc (1998) 0.87
Characterization of the chlorpropamide-alcohol-flush in patients with type 1 and type 2 diabetes. Acta Diabetol Lat (1983) 0.87
Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol (1999) 0.87
Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol (2002) 0.87
Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients. Diabetologia (1996) 0.86
Intravenous infusion of diarginylinsulin, an insulin analogue: effects on glucose turnover and lipid levels in insulin-treated type II diabetic patients. Metabolism (1992) 0.86
Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes (2001) 0.86
Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective. Clin Pharmacokinet (1989) 0.86
Cancer arising after pancreas and/or kidney transplantation in a series of 99 diabetic patients. Diabetes Care (1997) 0.86
Patient survival and cardiovascular events after kidney-pancreas transplantation: comparison with kidney transplantation alone in uremic IDDM patients. Cell Transplant (2001) 0.86
Persistence of counter-regulatory abnormalities in insulin-dependent diabetes mellitus after pancreas transplantation. Eur J Clin Invest (1994) 0.85
Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest (1996) 0.85
Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity. Diabetes Care (1994) 0.85
Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence. Acta Diabetol (1994) 0.85
Glycosylated haemoglobins and the oxygen affinity of whole blood. Diabetologia (1982) 0.85
The diabetic foot. General considerations and proposal of a new therapeutic and preventive approach. Diabetes Res Clin Pract (1993) 0.84
Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online. Hum Mutat (1998) 0.84
Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects. Metabolism (1999) 0.84
Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation. Diabetes (1989) 0.84
Effects of arginine and arginine plus somatostatin infusion on insulin release in diabetic patients submitted to pancreas allotransplantation. Diabete Metab (1988) 0.83